{"id":"W2003800151","doi":"10.1182/blood-2011-08-374777","title":"A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Providence Health Care; University of Toronto; Western University; Dalhousie University; University of Waterloo; Canadian Blood Services; Sunnybrook Health Science Centre; Grand River Hospital; Queen's University; McMaster University; University Health Network; Ottawa Hospital; Health Sciences Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Amgen; McMaster University; Sanofi; GlaxoSmithKline","keywords":"Medicine; Rituximab; Placebo; Internal medicine; Randomized controlled trial; Blinding; Clinical endpoint; Surgery; Gastroenterology; Lymphoma; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003836273,0.0002241008,0.001819304,0.0000772872,0.00005921586,0.000007890741,0.00007284283,0.0000539065,0.0001464927],"category_scores_gemma":[0.0003815889,0.0001238081,0.0002320197,0.0001071565,0.00008378542,0.0001029509,0.00002528553,0.00007404431,0.0000168124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000184014,"about_ca_system_score_gemma":0.0001176593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006801465,"about_ca_topic_score_gemma":0.00001227765,"domain_scores_codex":[0.998642,0.00008702802,0.0004635134,0.0001893406,0.0002595452,0.0003585542],"domain_scores_gemma":[0.9987038,0.0005266462,0.0002464407,0.0002817462,0.00011788,0.0001234243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9753121,0.02005449,0.002231355,0.00008755497,0.001364389,0.00001058104,0.0001456435,8.844757e-8,0.0003380897,0.00003159261,0.00005785082,0.0003662848],"study_design_scores_gemma":[0.9847919,0.005426849,0.001960699,0.000131126,0.002880043,0.00001827754,0.00001994642,0.000008154582,0.004494908,0.00002481303,0.00009188103,0.0001513604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914303,0.000469391,0.0001026984,0.00004477468,0.0001851622,0.006955026,0.0000866664,0.00003661966,0.0006893026],"genre_scores_gemma":[0.9949976,0.0000507408,0.003577407,0.00004248181,0.00007272744,0.0007311151,0.00018559,0.00003867109,0.0003036247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01462764,"threshold_uncertainty_score":0.5048749,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01787087140716527,"score_gpt":0.2675590350979816,"score_spread":0.2496881636908164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}